Michael T Boswell

8PUBLICATIONS
37CO-AUTHORS
Respiratory diseasesGene and molecular therapyNanotoxicology, health and safetyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 08, 2023
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence.

Michael T Boswell, Tshegofatso Maimela, Dan Hameiri-Bowen

|Apr 09, 2022
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

Roanne Keeton, Marius B Tincho, Amkele Ngomti

|Feb 01, 2022
T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

Roanne Keeton, Marius B Tincho, Amkele Ngomti

|Apr 07, 2021
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).

Thandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado

|Mar 03, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus

Pageof 2